Empyrean Capital Partners’s Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share LGV.WS Stock Holding History

Empyrean Capital Partners’s Portfolio LGV.WS Stock Details LGV.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-550,000	Closed	-$231K	–	187
2022 Q1	$231K	Hold	550,000	–	–	0.01%	164
2021 Q4	$467K	Hold	550,000	–	–	0.01%	152
2021 Q3	$710K	Buy	+550,000	New	+$741K	0.02%	152

Other funds holding LGV.WS

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

DMKJ

David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $190M AUM 31.84% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

PSAMP

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

Empyrean Capital Partners's LGV.WS Position: Q2 2022 in Review

Empyrean Capital Partners sold out of Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share (LGV.WS) in Q2 2022, closing a stake of 550,000 shares — an estimated $231K sold.

Empyrean Capital Partners first reported a position in LGV.WS in Q3 2021 and held it in 3 quarters. The position peaked at $710K in Q3 2021. 50 funds tracked by Wall St. Rank hold LGV.WS as of Q2 2022.

Empyrean Capital Partners reported no remaining Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position as of Q2 2022 after selling out during the quarter.
Empyrean Capital Partners sold 550,000 Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share shares in Q2 2022, an estimated $231K.
Empyrean Capital Partners first reported a position in Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share in Q3 2021 and held it in 3 quarters.
Empyrean Capital Partners's Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position peaked at $710K in Q3 2021.
50 funds tracked by Wall St. Rank held Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share as of Q2 2022.

Based on Empyrean Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.